The peptide therapeutics market would grow at a CAGR of 5.94% over the predicted time frame. The market is expected to increase in value from US$ 43.11 Bn in 2022 to US$ 76.83 Bn in 2032.
The on peptide therapeutics Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2548
A recent report provides crucial insights along with application based and forecast information in the Global Peptide therapeutics Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Peptide therapeutics market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Peptide therapeutics market are included as given below:
Peptide therapeutics Market Key Players
- Eli Lilly & Company
- Amgen Inc.
- Pfizer, Inc.
- Ever Neuro Pharma GmbH
- Bausch Health
- Abbvie
Market Segments
By Application
- Gastrointestinal Disorder
- Metabolic Disorder
- Neurological Disorder
- Cancer
- Others
By Type
- Generic
- Innovative
By Route of Administration
- Oral
- Parenteral
- Pulmonary
- Mucosal
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Drug Stores
By Synthesis Technology
- Solid Phase peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- The Middle East and Africa
Report Objectives
- To define, describe, and forecast the global peptide therapeutics market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the peptide therapeutics market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Peptide Therapeutics Market
5.1. COVID-19 Landscape: Peptide Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Peptide Therapeutics Market, By Application
8.1. Peptide Therapeutics Market, by Application, 2023-2032
8.1.1. Gastrointestinal Disorder
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Metabolic Disorder
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Neurological Disorder
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Cancer
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Peptide Therapeutics Market, By Type
9.1. Peptide Therapeutics Market, by Type, 2023-2032
9.1.1. Generic
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Innovative
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Peptide Therapeutics Market, By Route of Administration
10.1. Peptide Therapeutics Market, by Route of Administration, 2023-2032
10.1.1. Oral
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Parenteral
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Pulmonary
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Mucosal
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Peptide Therapeutics Market, By Distribution Channel
11.1. Peptide Therapeutics Market, by Distribution Channel, 2023-2032
11.1.1. Hospital Pharmacies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Retail Pharmacies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Online Drug Stores
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Peptide Therapeutics Market, By Synthesis Technology
12.1. Peptide Therapeutics Market, by Synthesis Technology, 2023-2032
12.1.1. Solid Phase peptide Synthesis (SPPS)
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Liquid Phase Peptide Synthesis (LPPS)
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Hybrid Technology
12.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Peptide Therapeutics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.6.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Type (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.7.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.7. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.8. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.10. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.11. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.13. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Type (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.15. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Type (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.9. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Type (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.7. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Type (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Route of Administration (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Synthesis Technology (2020-2032)
Chapter 14. Company Profiles
14.1. Eli Lilly & Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Amgen Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Pfizer, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Ever Neuro Pharma GmbH
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Bausch Health
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbvie
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments